https://www.selleckchem.com/pr....oducts/bay-k-8644.ht
[This corrects the article DOI 10.3389/fcell.2020.615154.].[This corrects the article DOI 10.3389/fcell.2020.00782.].Sustaining efficacious T cell-mediated antitumor immune responses in the tumor tissues is the key to the success of cancer immunotherapy. Current strategies leverage altering the signals T cells sense in the tumor microenvironment (TME). Checkpoint inhibitor-based approaches block inhibitory signals such as PD-1 whereas cytokine-based therapies increase the level of immune-stimulatory cytokines such as IL-2. Besides ex
Like
Comment
Share
